Cynosure, Inc. announced that it has received a medical device license issued by Health Canada to market MonaLisa Touch® for the treatment of symptoms related to Genitourinary Syndrome of Menopause (GSM),

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

Existing Users Log In
   
New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field